4
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0001562180-24-001994
SVP, Chief Operating Officer sold 10,744 shares at $1.52 ($16,331)
From the SEC's structured data for this filing
Trades in this filing
Dahan Michel · SVP, Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-27 | Sale : show line 1 in the form | −10,744 | $1.52 | $16,331 | 715,593 | D |
| Open-market sales · 10,744 sh · avg $1.52 · $16,331 | ||||||
Loading xslF345X05/primarydocument.xml…